{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T21:46:25Z","timestamp":1786139185052,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Consejeria","award":["PI20-0036"],"award-info":[{"award-number":["PI20-0036"]}]},{"DOI":"10.13039\/501100023731","name":"Consejer\u00eda de Salud y Consumo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI20-0036"],"award-info":[{"award-number":["PI20-0036"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Pi22-01718"],"award-info":[{"award-number":["Pi22-01718"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54778-5","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:14:33Z","timestamp":1779984873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic cytokine profiles across the progression of Type 1 diabetes mellitus are associated with diabetic retinopathy development"],"prefix":"10.1038","volume":"16","author":[{"given":"Francisco","family":"Mart\u00edn-Loro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Cano-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Lara-Barea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"G\u00f3mez-Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Carmen Gonz\u00e1lez-Montelongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Mar Roca-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"L\u00f3pez-Tinoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"\u00c1lvarez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Jim\u00e9nez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Campos-Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Aguilar-Diosdado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Arroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"54778_CR1","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s00125-021-05571-8","volume":"64","author":"A Green","year":"2021","unstructured":"Green, A. et al. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults Abbreviations CM Child mortality rate EURODIAB Europe and Diabetes GBD Global Burden of Disease HIC High-income country LIC Low-income country. Diabetologia 64, 2741\u20132750 (2021).","journal-title":"Diabetologia"},{"key":"54778_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01046-z","author":"D Tomic","year":"2025","unstructured":"Tomic, D., Harding, J. L., Jenkins, A. J., Shaw, J. E. & Magliano, D. J. The epidemiology of type 1 diabetes mellitus in older adults. Nature Research https:\/\/doi.org\/10.1038\/s41574-024-01046-z (2025).","journal-title":"Nature Research"},{"issue":"10","key":"54778_CR3","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s11886-022-01762-w","volume":"24","author":"JA Vanderniet","year":"2022","unstructured":"Vanderniet, J. A., Jenkins, A. J. & Donaghue, K. C. Epidemiology of type 1 diabetes. Curr. Cardiol. Rep. 24(10), 1455\u20131465. https:\/\/doi.org\/10.1007\/s11886-022-01762-w (2022).","journal-title":"Curr. Cardiol. Rep."},{"key":"54778_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2009.21","author":"DL Eizirik","year":"2009","unstructured":"Eizirik, D. L., Colli, M. L. & Ortis, F. The role of inflammation in insulitis and \u0392-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. https:\/\/doi.org\/10.1038\/nrendo.2009.21 (2009).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"54778_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.4239\/wjd.v6.i7.889","volume":"6","author":"C Mameli","year":"2015","unstructured":"Mameli, C. Explaining the increased mortality in type 1 diabetes. World J. Diabetes. 6 (7), 889. https:\/\/doi.org\/10.4239\/wjd.v6.i7.889 (2015).","journal-title":"World J. Diabetes"},{"issue":"1","key":"54778_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"DM Nathan","year":"2014","unstructured":"Nathan, D. M. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: Overview. Diabetes Care. 37 (1), 9\u201316. https:\/\/doi.org\/10.2337\/dc13-2112 (2014).","journal-title":"Diabetes Care"},{"issue":"March","key":"54778_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111615","volume":"210","author":"Z Jin","year":"2024","unstructured":"Jin, Z. et al. The association between interleukin family and diabetes mellitus and its complications: An overview of systematic reviews and meta-analyses. Diabetes Res. Clin. Pract. 210(March), 111615. https:\/\/doi.org\/10.1016\/j.diabres.2024.111615 (2024).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"54778_CR8","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.4049\/jimmunol.1000788","volume":"185","author":"J Honkanen","year":"2010","unstructured":"Honkanen, J. et al. IL-17 immunity in human type 1 diabetes. J. Immunol. 185(3), 1959\u20131967. https:\/\/doi.org\/10.4049\/jimmunol.1000788 (2010).","journal-title":"J. Immunol."},{"issue":"4","key":"54778_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00125-024-06098-4","volume":"67","author":"M Guo","year":"2024","unstructured":"Guo, M. et al. A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes. Diabetologia 67(4), 623\u2013640. https:\/\/doi.org\/10.1007\/s00125-024-06098-4 (2024).","journal-title":"Diabetologia"},{"key":"54778_CR10","doi-asserted-by":"crossref","unstructured":"Peter, J. & Delves First of Two Parts Three levels of defense. Adv. Immunol. 343(1),  37\u201349 (2000).","DOI":"10.1056\/NEJM200007063430107"},{"issue":"2","key":"54778_CR11","first-page":"95","volume":"1","author":"Y Le","year":"2004","unstructured":"Le, Y., Zhou, Y., Iribarren, P. & Wang, J. Chemokines and chemokine receptors: Their manifold roles in homeostasis and disease.. Cell. Mol. Immunol. 1(2), 95\u2013104 (2004).","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"54778_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1210\/edrv-16-2-164","volume":"16","author":"JF Pankewycz","year":"1995","unstructured":"Pankewycz, J. F., Guan, O. G. & Benedict, J.-X. Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocr. Rev. 16(2), 164\u2013176. https:\/\/doi.org\/10.1210\/edrv-16-2-164 (1995).","journal-title":"Endocr. Rev."},{"issue":"10","key":"54778_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1089\/jir.2011.0025","volume":"31","author":"B Singh","year":"2011","unstructured":"Singh, B., Nikoopour, E., Huszarik, K., Elliott, J. F. & Jevnikar, A. M. Immunomodulation and regeneration of islet beta cells by cytokines in autoimmune type 1 diabetes. J. Interferon Cytokine Res. 31(10), 711\u2013719. https:\/\/doi.org\/10.1089\/jir.2011.0025 (2011).","journal-title":"J. Interferon Cytokine Res."},{"issue":"24","key":"54778_CR14","doi-asserted-by":"publisher","first-page":"10908","DOI":"10.7150\/thno.48264","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Circular RNA circPPM1F modulates M1 macrophage activation and pancreatic islet inflammation in type 1 diabetes mellitus. Theranostics 10(24), 10908\u201310924. https:\/\/doi.org\/10.7150\/thno.48264 (2020).","journal-title":"Theranostics"},{"issue":"15","key":"54778_CR15","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.1073\/pnas.1815336116","volume":"116","author":"P Gao","year":"2019","unstructured":"Gao, P. et al. Risk variants disrupting enhancers of TH1 and TREG cells in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 116(15), 7581\u20137590. https:\/\/doi.org\/10.1073\/pnas.1815336116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"54778_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.preteyeres.2009.06.001","volume":"28","author":"H Xu","year":"2009","unstructured":"Xu, H., Chen, M. & Forrester, J. V. Para-inflammation in the aging retina. Prog. Retin. Eye Res. 28(5), 348\u2013368. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.06.001 (2009).","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"54778_CR17","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo, Z. L. et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology 128(11), 1580\u20131591. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.027 (2021).","journal-title":"Ophthalmology"},{"issue":"3","key":"54778_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2337\/dc20-0413","volume":"44","author":"CC Wykoff","year":"2021","unstructured":"Wykoff, C. C. et al. Risk of blindness among patients with diabetes and newly diagnosed diabetic retinopathy. Diabetes Care 44(3), 748\u2013756. https:\/\/doi.org\/10.2337\/dc20-0413 (2021).","journal-title":"Diabetes Care"},{"key":"54778_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.visres.2017.04.013","volume":"139","author":"H Xu","year":"2017","unstructured":"Xu, H. & Chen, M. Diabetic retinopathy and dysregulated innate immunity. Vis. Res. 139, 39\u201346. https:\/\/doi.org\/10.1016\/j.visres.2017.04.013 (2017).","journal-title":"Vis. Res."},{"issue":"2","key":"54778_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000342977","volume":"49","author":"UE Koskela","year":"2013","unstructured":"Koskela, U. E., Kuusisto, S. M., Nissinen, A. E., Savolainen, M. J. & Liinamaa, M. J. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy. Ophthalmic Res. 49(2), 108\u2013114. https:\/\/doi.org\/10.1159\/000342977 (2013).","journal-title":"Ophthalmic Res."},{"key":"54778_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030467","author":"G Obasanmi","year":"2023","unstructured":"Obasanmi, G. et al. Peripheral blood mononuclear cells from patients with type 1 diabetes and diabetic retinopathy produce higher levels of IL-17A, IL-10 and IL-6 and lower levels of IFN-\u03b3\u2014A pilot study. Cells https:\/\/doi.org\/10.3390\/cells12030467 (2023).","journal-title":"Cells"},{"key":"54778_CR22","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"D Care","year":"2021","unstructured":"Care, D. & Suppl, S. S. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care. 44, S15\u2013S33. https:\/\/doi.org\/10.2337\/dc21-S002 (2021).","journal-title":"Diabetes Care"},{"issue":"8","key":"54778_CR23","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino, T. et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care 42(8), 1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028 (2019).","journal-title":"Diabetes Care"},{"issue":"10","key":"54778_CR24","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","volume":"125","author":"TY Wong","year":"2018","unstructured":"Wong, T. Y. et al. Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings. Ophthalmology 125 (10), 1608\u20131622. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.007 (2018).","journal-title":"Ophthalmology"},{"key":"54778_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000442771","volume":"56","author":"PE Stanga","year":"2016","unstructured":"Stanga, P. E. et al. Swept-Source Optical Coherence Tomography Angio\u2122 (Topcon Corp, Japan): Technology review. Dev. Ophthalmol. 56, 13\u201317. https:\/\/doi.org\/10.1159\/000442771 (2016).","journal-title":"Dev. Ophthalmol."},{"issue":"1","key":"54778_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-022-02575-9","volume":"22","author":"R Zhu","year":"2022","unstructured":"Zhu, R. et al. Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study. BMC Ophthalmol. 22(1), 1\u201310. https:\/\/doi.org\/10.1186\/s12886-022-02575-9 (2022).","journal-title":"BMC Ophthalmol."},{"key":"54778_CR27","doi-asserted-by":"publisher","unstructured":"Vujosevic, S. & Retinal spots in normal and diabetic eyes. hyperreflective : B-Scan and En Face Spectral Domain Optical Coherence Tomography Evaluation, Retina, (2016). https:\/\/doi.org\/10.1097\/IAE.0000000000001304","DOI":"10.1097\/IAE.0000000000001304"},{"issue":"May","key":"54778_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.672455","volume":"12","author":"A Matejuk","year":"2021","unstructured":"Matejuk, A., Vandenbark, A. A. & Offner, H. Cross-talk of the CNS with immune cells and functions in health and disease. Front. Neurol. 12(May), 1\u201319. https:\/\/doi.org\/10.3389\/fneur.2021.672455 (2021).","journal-title":"Front. Neurol."},{"issue":"6","key":"54778_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060855","volume":"60","author":"NT Tabakoglu","year":"2024","unstructured":"Tabakoglu, N. T. & Celik, M. Investigation of the Systemic Immune Inflammation (SII) Index as an indicator of morbidity and mortality in type 2 diabetic retinopathy patients in a 4-year follow-up period. Medicina 60(6), 855. https:\/\/doi.org\/10.3390\/medicina60060855 (2024).","journal-title":"Medicina"},{"issue":"1","key":"54778_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-024-03476-y","volume":"22","author":"J Van Rampelbergh","year":"2024","unstructured":"Van Rampelbergh, J. et al. First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: An exploratory analysis of immune biomarkers. BMC Med. 22(1), 1\u201313. https:\/\/doi.org\/10.1186\/s12916-024-03476-y (2024).","journal-title":"BMC Med."},{"issue":"July","key":"54778_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1219598","volume":"14","author":"L Reynolds","year":"2023","unstructured":"Reynolds, L., Luo, Z. & Singh, K. Diabetic complications and prospective immunotherapy. Front. Immunol. 14(July), 1\u201318. https:\/\/doi.org\/10.3389\/fimmu.2023.1219598 (2023).","journal-title":"Front. Immunol."},{"issue":"3","key":"54778_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000478784","volume":"58","author":"P Voabil","year":"2017","unstructured":"Voabil, P. et al. Calcium Dobesilate is protective against inflammation and oxidative\/nitrosative stress in the retina of a type 1 diabetic rat model. Ophthalmic Res. 58(3), 150\u2013161. https:\/\/doi.org\/10.1159\/000478784 (2017).","journal-title":"Ophthalmic Res."},{"issue":"1","key":"54778_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1373-4","volume":"15","author":"D Kokona","year":"2018","unstructured":"Kokona, D., Ebneter, A., Escher, P. & Zinkernagel, M. S. Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation. J. Neuroinflammation. 15 (1), 1\u201318. https:\/\/doi.org\/10.1186\/s12974-018-1373-4 (2018).","journal-title":"J. Neuroinflammation"},{"issue":"November","key":"54778_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.564077","volume":"11","author":"UM Kinuthia","year":"2020","unstructured":"Kinuthia, U. M., Wolf, A. & Langmann, T. Microglia and inflammatory responses in diabetic retinopathy. Front. Immunol. 11(November), 1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2020.564077 (2020).","journal-title":"Front. Immunol."},{"issue":"5","key":"54778_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm11051303","volume":"11","author":"F Cano-Cano","year":"2022","unstructured":"Cano-Cano, F., G\u00f3mez-Jaramillo, L., Ramos-Garc\u00eda, P., Arroba, A. I. & Aguilar-Diosdado, M. IL-1\u03b2 implications in type 1 diabetes mellitus progression: Systematic review and meta-analysis. J. Clin. Med. 11(5), 1\u201318. https:\/\/doi.org\/10.3390\/jcm11051303 (2022).","journal-title":"J. Clin. Med."},{"issue":"2","key":"54778_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.circir.2015.04.003","volume":"83","author":"SE Hern\u00e1ndez-Da Mota","year":"2015","unstructured":"Hern\u00e1ndez-Da Mota, S. E., Soto-Bahena, J. J., Viveros-Sandoval, M. E. & Cardiel-R\u00edos, M. Citoquinas s\u00e9ricas proinflamatorias en retinopat\u00eda diab\u00e9tica. Cir. Cir. 83(2), 100\u2013106. https:\/\/doi.org\/10.1016\/j.circir.2015.04.003 (2015).","journal-title":"Cir. Cir."},{"key":"54778_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15151906","author":"R Asif","year":"2025","unstructured":"Asif, R. et al. Role of interleukins in Type 1 and Type 2 Diabetes. Diagnostics https:\/\/doi.org\/10.3390\/diagnostics15151906 (2025).","journal-title":"Diagnostics"},{"issue":"10","key":"54778_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.4239\/wjd.v13.i10.835","volume":"13","author":"G Nagy","year":"2022","unstructured":"Nagy, G., Szekely, T. E., Somogyi, A., Herold, M. & Herold, Z. New therapeutic approaches for Type 1 Diabetes: Disease-modifying therapies. World J. Diabetes 13(10), 835\u2013850. https:\/\/doi.org\/10.4239\/wjd.v13.i10.835 (2022).","journal-title":"World J. Diabetes"},{"key":"54778_CR39","doi-asserted-by":"publisher","unstructured":"Mason, R. H. et al. Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis, Eye (Basingstoke), 1\u201351, (2022). https:\/\/doi.org\/10.1038\/s41433-022-02127-x","DOI":"10.1038\/s41433-022-02127-x"},{"issue":"February","key":"54778_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1088778","volume":"14","author":"Q Shi","year":"2023","unstructured":"Shi, Q., Wang, Q., Wang, Z., Lu, J. & Wang, R. Systemic inflammatory regulators and proliferative diabetic retinopathy: A bidirectional Mendelian randomization study. Front. Immunol. 14(February), 1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2023.1088778 (2023).","journal-title":"Front. Immunol."},{"key":"54778_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/nri3862 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"54778_CR42","doi-asserted-by":"crossref","unstructured":"Pickup, J. C. Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes, [Online]. (2004). Available: http:\/\/diabetesjournals.org\/care\/article-pdf\/27\/3\/813\/648573\/zdc00304000813.pdf","DOI":"10.2337\/diacare.27.3.813"},{"issue":"October","key":"54778_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.790255","volume":"13","author":"J Carmichael","year":"2022","unstructured":"Carmichael, J., Fadavi, H. & Tavakoli, M. Neurodegeneration of the cornea and retina in patients with type 1 diabetes without clinical evidence of diabetic retinopathy. Front. Endocrinol. (Lausanne). 13(October), 1\u201311. https:\/\/doi.org\/10.3389\/fendo.2022.790255 (2022).","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"5","key":"54778_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/IAE.0000000000004028","volume":"44","author":"Y Guo","year":"2024","unstructured":"Guo, Y., Zheng, X., He, H. & Zheng, S. Retinal microvasculopathy with different insulin infusion therapies in children with type 1 diabetes mellitus without clinical diabetic retinopathy. Retina 44(5), 895\u2013900. https:\/\/doi.org\/10.1097\/IAE.0000000000004028 (2024).","journal-title":"Retina"},{"issue":"1","key":"54778_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00210-024-03360-9","volume":"398","author":"D Wang","year":"2025","unstructured":"Wang, D. & Liu, R. The IL-12 family of cytokines: Pathogenetic role in diabetic retinopathy and therapeutic approaches to correction. Naunyn Schmiedebergs Arch. Pharmacol. 398(1), 125\u2013133. https:\/\/doi.org\/10.1007\/s00210-024-03360-9 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"54778_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/274726","author":"K Semeran","year":"2013","unstructured":"Semeran, K. et al. Plasma levels of il-17, VEGF, and adrenomedullin and s-cone dysfunction of the retina in children and adolescents without signs of retinopathy and with varied duration of diabetes. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2013\/274726 (2013).","journal-title":"Mediators Inflamm."},{"issue":"6","key":"54778_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.202202056RR","volume":"37","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Interleukin-17A modulates retinal inflammation by regulating microglial activation via the p38 MAPK pathway in experimental glaucoma neuropathy. FASEB J. 37(6), 1\u201324. https:\/\/doi.org\/10.1096\/fj.202202056RR (2023).","journal-title":"FASEB J."},{"key":"54778_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1051-6","author":"AY Fouda","year":"2018","unstructured":"Fouda, A. Y. et al. Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responses. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-018-1051-6 (2018).","journal-title":"Cell Death Dis."},{"issue":"March","key":"54778_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.632132","volume":"12","author":"F Cano-Cano","year":"2021","unstructured":"Cano-Cano, F. et al. Anti-inflammatory (M2) response is induced by a sp2-iminosugar glycolipid sulfoxide in diabetic retinopathy. Front. Immunol. 12(March), 1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2021.632132 (2021).","journal-title":"Front. Immunol."},{"key":"54778_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.973025","author":"J Mao","year":"2022","unstructured":"Mao, J. et al. Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2022.973025 (2022).","journal-title":"Front. Med."},{"key":"54778_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021024","author":"K Gomu\u0142ka","year":"2023","unstructured":"Gomu\u0142ka, K. & Ruta, M. The role of inflammation and therapeutic concepts in diabetic retinopathy\u2014A short review. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24021024 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"54778_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12031-015-0505-x","volume":"56","author":"S Scuderi","year":"2015","unstructured":"Scuderi, S. et al. Different retinal expression patterns of IL-1\u03b1, IL-1\u03b2, and their receptors in a rat model of type 1 STZ-induced diabetes. J. Mol. Neurosci. 56(2), 431\u2013439. https:\/\/doi.org\/10.1007\/s12031-015-0505-x (2015).","journal-title":"J. Mol. Neurosci."},{"key":"54778_CR53","doi-asserted-by":"crossref","unstructured":"Berman 1, B. A. B. M. A. et al. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J. Immunol. 157 (10), 4690\u20134696 (1996).","DOI":"10.4049\/jimmunol.157.10.4690"},{"key":"54778_CR54","doi-asserted-by":"publisher","unstructured":"Van Der Torren, C. R. et al. Serum cytokines as biomarkers in islet cell transplantation for type 1 diabetes. PLoS One 11(1), 1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0146649 (2016).","DOI":"10.1371\/journal.pone.0146649"},{"issue":"May","key":"54778_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2022.873483","volume":"9","author":"M Amorim","year":"2022","unstructured":"Amorim, M. et al. Putative biomarkers in tears for diabetic retinopathy diagnosis. Front. Med. (Lausanne). 9(May), 1\u201315. https:\/\/doi.org\/10.3389\/fmed.2022.873483 (2022).","journal-title":"Front. Med. (Lausanne)."},{"issue":"1","key":"54778_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/0366-6999.221263","volume":"131","author":"XF Yang","year":"2018","unstructured":"Yang, X. F., Huang, Y. X., Lan, M., Zhang, T. R. & Zhou, J. Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice. Chin. Med. J. (Engl). 131 (1), 75\u201381. https:\/\/doi.org\/10.4103\/0366-6999.221263 (2018).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"1","key":"54778_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11717","volume":"25","author":"J Lv","year":"2022","unstructured":"Lv, J., Gao, R., Wang, Y., Huang, C. & Wu, R. Protective effect of Leukemia Inhibitory Factor on the retinal injury induced by acute ocular hypertension in rats. Exp. Ther. Med. 25(1), 1\u201310. https:\/\/doi.org\/10.3892\/etm.2022.11717 (2022).","journal-title":"Exp. Ther. Med."},{"issue":"November 2013","key":"54778_CR58","first-page":"1137","volume":"20","author":"H Hang","year":"2014","unstructured":"Hang, H., Yuan, S., Yang, Q., Yuan, D. & Liu, Q. Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy. Mol. Vis. 20(November 2013), 1137\u20131145 (2014).","journal-title":"Mol. Vis."},{"issue":"1","key":"54778_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjophth-2021-000717","volume":"6","author":"JU Quevedo-Mart\u00ednez","year":"2021","unstructured":"Quevedo-Mart\u00ednez, J. U. et al. Pro-inflammatory cytokine profile is present in the serum of Mexican patients with different stages of diabetic retinopathy secondary to type 2 diabetes. BMJ Open Ophthalmol. 6(1), 1\u201310. https:\/\/doi.org\/10.1136\/bmjophth-2021-000717 (2021).","journal-title":"BMJ Open Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54778-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54778-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54778-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T21:01:36Z","timestamp":1786136496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54778-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54778"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54778-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"This study was approved by the institutional Research Ethics Committee of the province of Cadiz (registration number 05.23). All subjects or their tutors gave written informed consents following the Declaration of Helsinki. All data were pseudo-anonymized to preclude patient\/donor identification and were included in a database to which only the researchers had access.","order":2,"name":"Ethics","label":"Ethics approvals","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the data and the images in Fig.\u00a02.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"24492"}}